MDxHealth S.A.
NASDAQ:MDXHMedical - Diagnostics & Research
Healthcare
$0.60 -4.45%
-$0.03 today
- Market cap
- $57.59M
- Beta
- 0.38
- P/E (TTM)
- -1.0
- EPS (TTM)
- -$0.58
52W Low $0.40High $5.33
Volume 0.65M
Average 4.27M
Cash Flow
Check whether earnings turn into cash.
Operating Cash Flow
-$10.42M
FY 2025 · Annual
Investing Cash Flow
-$20.06M
FY 2025 · Annual
Financing Cash Flow
$12.70M
FY 2025 · Annual
-71.5% YoYCash Flow Statement
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (26.84M) | (37.9M) | (27.33M) | (24.72M) | (14.41M) |
| Depreciation & Amortization | 3.04M | 4.91M | 6.86M | 8.04M | 9.21M |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 1.22M | 867K | 665K | 1.73M | 2.21M |
| Change in Working Capital | 360K | (1.57M) | (2.12M) | (3.86M) | 939K |
| Accounts Receivables | (1.38M) | (5.12M) | (1.68M) | (3.23M) | 2.32M |
| Inventory | 413K | (416K) | (452K) | (1.09M) | (1.93M) |
| Accounts Payables | 0 | 0 | 0 | 0 | 550K |
| Other Working Capital | 1.33M | 3.97M | 20K | 458K | 0 |
| Other Non-Cash Items | (325K) | (429K) | 421K | 286K | (8.37M) |
| Operating Cash Flow | (22.55M) | (34.12M) | (21.5M) | (18.53M) | (10.42M) |
| Capital Expenditures | (896K) | (4.16M) | (5.02M) | (2.16M) | (1.16M) |
| Acquisitions (Net) | 0 | (25M) | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 11K | (1.25M) | (1.18M) | (448K) | (18.9M) |
| Investing Cash Flow | (885K) | (29.04M) | (3.93M) | (1.64M) | (20.06M) |
| Debt Repayment | (1.06M) | 22.13M | (3.27M) | 11.59M | 21.6M |
| Common Stock Issued | 68.57M | 0 | 39.6M | 40.74M | 0 |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (1.01M) | (1.41M) | (4.05M) | (7.73M) | (8.91M) |
| Financing Cash Flow | 66.5M | 20.72M | 32.28M | 44.6M | 12.7M |
| Effect of Forex Changes | (520K) | (555K) | 25K | (14K) | 16K |
| Net Change in Cash | 42.55M | (43M) | 6.88M | 24.42M | (17.77M) |
| Free Cash Flow | (23.44M) | (38.28M) | (26.52M) | (20.69M) | (11.57M) |
Free Cash Flow
Net Income to FCF bridge
FY2025
= Net Income-$14.4M
+ D&A$9.2M
+ Stock-Based Comp$2.2M
+ Deferred Tax$0
+ Working Capital$939.0K
- Other Non-Cash-$8.4M
= Operating Cash Flow-$10.4M
- Capex-$1.2M
= Free Cash Flow-$11.6M
Analysis
FY2025 free cash flow is -$11.6M. FCF conversion is 80.3% of net income. Operating cash flow was -$10.4M, with capex of -$1.2M. The largest bridge item is D&A at $9.2M.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| SC 13D/A | SC 13D/A filing | Oct 15, 2026 | |
| 144 | Notice of proposed sale of securities | Sep 17, 2026 | |
| 6-K | 6-K filing | Sep 3, 2026 | |
| SC 13G/A | SC 13G/A filing | Aug 17, 2026 | |
| 4 | Statement of changes in beneficial ownership | Aug 17, 2026 |
Does MDXH generate free cash flow?
MDxHealth S.A. (MDXH) generated -$11.57M of free cash flow in fiscal 2025.
How much operating cash flow does MDXH produce?
Operating cash flow was -$10.42M, before capital expenditures of $1.16M.
Continue the stock analysis
Jump to another research area for this company.